Latest Insider Transactions at Bridge Bio Pharma, Inc. (BBIO)
This section provides a real-time view of insider transactions for Bridge Bio Pharma, Inc. (BBIO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BridgeBio Pharma, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BridgeBio Pharma, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 16
2022
|
Brian C Stephenson Secretary, Treasurer & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,228
-2.77%
|
$55,368
$6.74 P/Share
|
|
May 16
2022
|
Brian C Stephenson Secretary, Treasurer & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
26,680
+7.42%
|
-
|
|
May 16
2022
|
Neil Kumar Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
23,759
-0.5%
|
$142,554
$6.74 P/Share
|
|
May 16
2022
|
Neil Kumar Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
68,705
+1.41%
|
-
|
|
May 16
2022
|
Richard H Scheller Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,310
-2.67%
|
$7,860
$6.74 P/Share
|
|
May 16
2022
|
Richard H Scheller Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,195
+6.11%
|
-
|
|
Mar 15
2022
|
Andrea Ellis |
BUY
Open market or private purchase
|
Direct |
12,000
+50.0%
|
$96,000
$8.39 P/Share
|
|
Mar 14
2022
|
Douglas A. Dachille |
BUY
Open market or private purchase
|
Indirect |
10,000
+33.33%
|
$80,000
$8.19 P/Share
|
|
Feb 16
2022
|
Brian C Stephenson Secretary, Treasurer & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,020
-0.33%
|
$8,160
$8.84 P/Share
|
|
Feb 16
2022
|
Brian C Stephenson Secretary, Treasurer & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,488
+0.8%
|
-
|
|
Feb 16
2022
|
Neil Kumar Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,085
-0.07%
|
$24,680
$8.84 P/Share
|
|
Feb 16
2022
|
Neil Kumar Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,524
+0.16%
|
-
|
|
Jan 05
2022
|
Douglas A. Dachille |
BUY
Open market or private purchase
|
Indirect |
5,000
+33.33%
|
$75,000
$15.91 P/Share
|
|
Jan 04
2022
|
Douglas A. Dachille |
BUY
Open market or private purchase
|
Indirect |
5,000
+50.0%
|
$80,000
$16.82 P/Share
|
|
Dec 30
2021
|
Andrew Lo |
BUY
Open market or private purchase
|
Direct |
1,500
+3.02%
|
$21,000
$14.3 P/Share
|
|
Dec 30
2021
|
Ronald J Daniels |
BUY
Open market or private purchase
|
Direct |
10,402
+50.0%
|
$145,628
$14.34 P/Share
|
|
Dec 29
2021
|
James C Momtazee |
BUY
Open market or private purchase
|
Direct |
80,000
+47.48%
|
$1,120,000
$14.5 P/Share
|
|
Dec 29
2021
|
Fred Hassan |
BUY
Open market or private purchase
|
Direct |
19,300
+50.0%
|
$270,200
$14.17 P/Share
|
|
Dec 29
2021
|
Hannah Valantine |
BUY
Open market or private purchase
|
Direct |
1,764
+50.0%
|
$24,696
$14.23 P/Share
|
|
Dec 29
2021
|
Andrew Lo |
BUY
Open market or private purchase
|
Direct |
6,000
+11.41%
|
$72,000
$12.9 P/Share
|
|
Dec 29
2021
|
Brent L Saunders Director |
BUY
Open market or private purchase
|
Direct |
17,600
+50.0%
|
$246,400
$14.48 P/Share
|
|
Dec 28
2021
|
Hannah Valantine |
BUY
Open market or private purchase
|
Indirect |
3,433
+40.5%
|
$41,196
$12.93 P/Share
|
|
Dec 28
2021
|
Ronald J Daniels |
SELL
Open market or private sale
|
Direct |
11,745
-100.0%
|
$140,940
$12.8 P/Share
|
|
Dec 28
2021
|
Ronald J Daniels |
BUY
Open market or private purchase
|
Direct |
11,745
+50.0%
|
$140,940
$12.73 P/Share
|
|
Nov 16
2021
|
Jennifer E. Cook |
BUY
Exercise of conversion of derivative security
|
Direct |
3,576
+33.33%
|
-
|
|
Nov 16
2021
|
Brian C Stephenson Secretary, Treasurer & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,234
-0.4%
|
$57,998
$47.25 P/Share
|
|
Nov 16
2021
|
Brian C Stephenson Secretary, Treasurer & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,488
+0.81%
|
-
|
|
Nov 16
2021
|
Neil Kumar Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,730
-0.08%
|
$175,310
$47.25 P/Share
|
|
Nov 16
2021
|
Neil Kumar Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,523
+0.16%
|
-
|
|
Aug 16
2021
|
Neil Kumar Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,730
-0.08%
|
$182,770
$49.48 P/Share
|
|
Aug 16
2021
|
Neil Kumar Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,523
+0.16%
|
-
|
|
Aug 16
2021
|
Brian C Stephenson Secretary, Treasurer & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,028
-0.34%
|
$50,372
$49.48 P/Share
|
|
Aug 16
2021
|
Brian C Stephenson Secretary, Treasurer & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,487
+0.81%
|
-
|
|
Aug 04
2021
|
Richard H Scheller Director |
SELL
Open market or private sale
|
Direct |
13,777
-23.1%
|
$730,181
$53.23 P/Share
|
|
Aug 04
2021
|
Richard H Scheller Director |
BUY
Exercise of conversion of derivative security
|
Direct |
13,777
+18.77%
|
$234,209
$17.0 P/Share
|
|
May 16
2021
|
Brian C Stephenson Secretary, Treasurer & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
862
-0.28%
|
$45,686
$53.66 P/Share
|
|
May 16
2021
|
Brian C Stephenson Secretary, Treasurer & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,488
+0.82%
|
-
|
|
May 16
2021
|
Neil Kumar Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,731
-0.08%
|
$197,743
$53.66 P/Share
|
|
May 16
2021
|
Neil Kumar Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,524
+0.16%
|
-
|
|
Mar 01
2021
|
Charles J Homcy |
SELL
Payment of exercise price or tax liability
|
Direct |
524
-0.04%
|
$37,204
$71.91 P/Share
|
|
Mar 01
2021
|
Charles J Homcy |
BUY
Grant, award, or other acquisition
|
Direct |
1,521
+0.13%
|
-
|
|
Feb 17
2021
|
Randal W. Scott |
BUY
Open market or private purchase
|
Direct |
16,000
+43.24%
|
$992,000
$62.5 P/Share
|
|
Feb 17
2021
|
Neil Kumar Chief Executive Officer |
BUY
Payment of exercise price or tax liability
|
Direct |
16,000
+0.34%
|
$992,000
$62.5 P/Share
|
|
Feb 17
2021
|
Brian C Stephenson Secretary, Treasurer & CFO |
BUY
Open market or private purchase
|
Direct |
8,000
+2.6%
|
$496,000
$62.5 P/Share
|
|
Feb 17
2021
|
Kkr Genetic Disorder L.P. |
SELL
Open market or private sale
|
Indirect |
3,450,000
-10.0%
|
$207,000,000
$60.47 P/Share
|
|
Feb 16
2021
|
Neil Kumar Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,139
-0.05%
|
$136,896
$64.98 P/Share
|
|
Feb 16
2021
|
Neil Kumar Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,129
+0.11%
|
-
|
|
Feb 16
2021
|
Brian C Stephenson Secretary, Treasurer & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
592
-0.2%
|
$37,888
$64.98 P/Share
|
|
Feb 16
2021
|
Brian C Stephenson Secretary, Treasurer & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,710
+0.58%
|
-
|
|
Dec 28
2020
|
Cameron Turtle Officer |
SELL
Open market or private sale
|
Direct |
19,500
-37.31%
|
$1,345,500
$69.64 P/Share
|